<code id='E92FB26E8A'></code><style id='E92FB26E8A'></style>
    • <acronym id='E92FB26E8A'></acronym>
      <center id='E92FB26E8A'><center id='E92FB26E8A'><tfoot id='E92FB26E8A'></tfoot></center><abbr id='E92FB26E8A'><dir id='E92FB26E8A'><tfoot id='E92FB26E8A'></tfoot><noframes id='E92FB26E8A'>

    • <optgroup id='E92FB26E8A'><strike id='E92FB26E8A'><sup id='E92FB26E8A'></sup></strike><code id='E92FB26E8A'></code></optgroup>
        1. <b id='E92FB26E8A'><label id='E92FB26E8A'><select id='E92FB26E8A'><dt id='E92FB26E8A'><span id='E92FB26E8A'></span></dt></select></label></b><u id='E92FB26E8A'></u>
          <i id='E92FB26E8A'><strike id='E92FB26E8A'><tt id='E92FB26E8A'><pre id='E92FB26E8A'></pre></tt></strike></i>

          focus

          focus

          author:entertainment    Page View:365

          Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET.

          STAT’s reporters, strung-out from several days of ASCO madness, will take the virtual stage to share convention hall insights, predictions for the months ahead, and of course will take your audience questions live.

          advertisement

          Sponsor Introduction

          • Ashwin Athri, EVP, strategy, innovation, & partnerships, Precision AQ

          Featured Speakers

          • Angus Chen, cancer reporter, STAT
          • Adam Feuerstein, senior writer, biotech, STAT
          • Matthew Herper, senior writer, medicine; editorial director of events, STAT
          • Katherine MacPhail, programmer, editorial events, STAT (moderator)

          Sponsored By

          explore

          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more
          Oral obesity drug from Viking Therapeutics hits key early target
          Oral obesity drug from Viking Therapeutics hits key early target

          DrewAngerer/GettyImagesVikingTherapeuticssaidTuesdaythatitscloselywatchedoralobesitydrughadsucceeded

          read more
          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more

          U.K. decision on ALS drug has neurologists, advocates up in arms

          TheALSdrugtofersenismarketedasQalsodyintheU.S.BiogenLONDON—Neurologistsandpatientadvocatesareupinarm